Literature DB >> 16763900

Treatment with amino acids in serine deficiency disorders.

T J de Koning1.   

Abstract

Serine deficiency disorders are rare defects in the biosynthesis of the amino acid L-serine. At present two disorders have been reported: 3-phosphoglycerate dehydrogenase deficiency and 3-phosphoserine phosphatase deficiency. These enzyme defects lead to severe neurological symptoms such as congenital microcephaly and severe psychomotor retardation and in addition in patients with 3-phosphoglycerate dehydrogenase deficiency to intractable seizures. These symptoms respond to a variable degree to treatment with L-serine, sometimes combined with glycine. In this paper the current practice of amino acid treatment with L-serine and glycine in serine deficiency is reviewed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763900     DOI: 10.1007/s10545-006-0269-0

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  22 in total

1.  Phosphoserine phosphatase deficiency in a patient with Williams syndrome.

Authors:  J Jaeken; M Detheux; J P Fryns; J F Collet; P Alliet; E Van Schaftingen
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  V490M, a common mutation in 3-phosphoglycerate dehydrogenase deficiency, causes enzyme deficiency by decreasing the yield of mature enzyme.

Authors:  Steven Pind; Elzbieta Slominski; Jill Mauthe; Kayla Pearlman; Kathryn J Swoboda; John A Wilkins; Patricia Sauder; Marvin R Natowicz
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

3.  Autoantibodies to folate receptors in the cerebral folate deficiency syndrome.

Authors:  Vincent T Ramaekers; Sheldon P Rothenberg; Jeffrey M Sequeira; Thomas Opladen; Nenad Blau; Edward V Quadros; Jacob Selhub
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

4.  D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor.

Authors:  J P Mothet; A T Parent; H Wolosker; R O Brady; D J Linden; C D Ferris; M A Rogawski; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

5.  Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine.

Authors:  Y Y Tyurina; A A Shvedova; K Kawai; V A Tyurin; C Kommineni; P J Quinn; N F Schor; J P Fabisiak; V E Kagan
Journal:  Toxicology       Date:  2000-08-07       Impact factor: 4.221

6.  3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome.

Authors:  M Pineda; M A Vilaseca; R Artuch; S Santos; M M García González; A Aracil; E Van Schaftingen; J Jaeken
Journal:  Dev Med Child Neurol       Date:  2000-09       Impact factor: 5.449

7.  Enzymes of serine metabolism in normal, developing and neoplastic rat tissues.

Authors:  K Snell
Journal:  Adv Enzyme Regul       Date:  1984

8.  Characterization and localization of a human serine racemase.

Authors:  Menghang Xia; Yuan Liu; David J Figueroa; Chi-Sung Chiu; Nan Wei; Ann-Marie Lawlor; Ping Lu; Cyrille Sur; Ken S Koblan; Thomas M Connolly
Journal:  Brain Res Mol Brain Res       Date:  2004-06-18

9.  Mutations responsible for 3-phosphoserine phosphatase deficiency.

Authors:  Maria Veiga-da-Cunha; Jean-François Collet; Benoît Prieur; Jaak Jaeken; Yves Peeraer; Anja Rabbijns; Emile Van Schaftingen
Journal:  Eur J Hum Genet       Date:  2004-02       Impact factor: 4.246

10.  Kinetics of neutral amino acid transport across the blood-brain barrier.

Authors:  Q R Smith; S Momma; M Aoyagi; S I Rapoport
Journal:  J Neurochem       Date:  1987-11       Impact factor: 5.372

View more
  16 in total

1.  Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway.

Authors:  Rocio Acuna-Hidalgo; Denny Schanze; Ariana Kariminejad; Ann Nordgren; Mohamad Hasan Kariminejad; Peter Conner; Giedre Grigelioniene; Daniel Nilsson; Magnus Nordenskjöld; Anna Wedell; Christoph Freyer; Anna Wredenberg; Dagmar Wieczorek; Gabriele Gillessen-Kaesbach; Hülya Kayserili; Nursel Elcioglu; Siavash Ghaderi-Sohi; Payman Goodarzi; Hamidreza Setayesh; Maartje van de Vorst; Marloes Steehouwer; Rolph Pfundt; Birgit Krabichler; Cynthia Curry; Malcolm G MacKenzie; Kym M Boycott; Christian Gilissen; Andreas R Janecke; Alexander Hoischen; Martin Zenker
Journal:  Am J Hum Genet       Date:  2014-08-21       Impact factor: 11.025

2.  Brain-specific Phgdh deletion reveals a pivotal role for L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate receptor co-agonist, in adult brain.

Authors:  Jung Hoon Yang; Akira Wada; Kazuyuki Yoshida; Yurika Miyoshi; Tomoko Sayano; Kayoko Esaki; Masami O Kinoshita; Shozo Tomonaga; Norihiro Azuma; Masahiko Watanabe; Kenji Hamase; Kiyoshi Zaitsu; Takeo Machida; Albee Messing; Shigeyoshi Itohara; Yoshio Hirabayashi; Shigeki Furuya
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

3.  Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of L-Serine.

Authors:  Walter G Bradley; R X Miller; T D Levine; E W Stommel; P A Cox
Journal:  Neurotox Res       Date:  2017-05-19       Impact factor: 3.911

4.  Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.

Authors:  Kevin Garofalo; Anke Penno; Brian P Schmidt; Ho-Joon Lee; Matthew P Frosch; Arnold von Eckardstein; Robert H Brown; Thorsten Hornemann; Florian S Eichler
Journal:  J Clin Invest       Date:  2011-12       Impact factor: 14.808

Review 5.  Clinical approach to treatable inborn metabolic diseases: an introduction.

Authors:  J-M Saudubray; F Sedel; J H Walter
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

6.  Inactivation of the 3-phosphoglycerate dehydrogenase gene in mice: changes in gene expression and associated regulatory networks resulting from serine deficiency.

Authors:  Shigeki Furuya; Kazuyuki Yoshida; Yuriko Kawakami; Jyung Hoon Yang; Tomoko Sayano; Norihiro Azuma; Hideyuki Tanaka; Satoru Kuhara; Yoshio Hirabayashi
Journal:  Funct Integr Genomics       Date:  2008-01-29       Impact factor: 3.410

7.  Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay.

Authors:  Salma Ben-Salem; Joseph G Gleeson; Aisha M Al-Shamsi; Barira Islam; Jozef Hertecant; Bassam R Ali; Lihadh Al-Gazali
Journal:  Metab Brain Dis       Date:  2014-09-17       Impact factor: 3.584

8.  Protein expression is altered during spontaneous sleep in aged Sprague Dawley rats.

Authors:  Jacqueline Vazquez; Steven C Hall; Mary Ann Greco
Journal:  Brain Res       Date:  2009-08-31       Impact factor: 3.252

9.  Novel Report of Phosphoserine Phosphatase Deficiency in an Adult with Myeloneuropathy and Limb Contractures.

Authors:  Heather M Byers; Robin L Bennett; Emily A Malouf; Michael D Weiss; Jie Feng; C Ronald Scott; Suman Jayadev
Journal:  JIMD Rep       Date:  2015-11-21

10.  Glutamine supplementation in a child with inherited GS deficiency improves the clinical status and partially corrects the peripheral and central amino acid imbalance.

Authors:  Johannes Häberle; Noora Shahbeck; Khalid Ibrahim; Bernhard Schmitt; Ianina Scheer; Ruth O'Gorman; Farrukh A Chaudhry; Tawfeg Ben-Omran
Journal:  Orphanet J Rare Dis       Date:  2012-07-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.